Alternatively, elevated autoantibodies to GluA1 without changes in GluA1 peptides may serve as a very early indicator of cognitive impairment in contact sport athletes that precedes manifestation of GluA1 degradation. Here, GRIA1 is linked to Cognitive impairment.